Q1 Biopharma Recap
- 22 April 2024
In Conversation: Dr. Shane Hegarty from Axonis Therapeutics
- 8 February 2024
2023 Biopharma Funding Recap: Beyond the Surface
- 24 January 2024
Why Your Cold Outreach to Biotechs is Failing… And How to Fix It
- 25 October 2022
Navigating Novo: A Map for Selling to Novo Nordisk
- 14 October 2019
2023 Biopharma Funding Recap: Beyond the Surface
- 24 January 2024
Latest Posts
- Alec de la Durantaye
- Industry Articles
- 6 March 2024
Why Your Cold Outreach to Biotechs (Still) isn't Working: A Battle with AI
Goals & Hurdles
- Alec de la Durantaye
- Discovering Biotech Startups
- 8 February 2024
In Conversation: Dr. Shane Hegarty from Axonis Therapeutics
AXONIS Therapeutics is a Boston-based biotech dedicated to advancing breakthrough therapies in...
- Alec de la Durantaye
- Industry Articles
- 24 January 2024
2023 Biopharma Funding Recap: Beyond the Surface
Review of 2023 Biopharma Funding: How can sales and business development teams at service providers...